Davis Aaron I. 4
4 · Rain Therapeutics Inc. · Filed Nov 8, 2022
Insider Transaction Report
Form 4
Davis Aaron I.
Director10% Owner
Transactions
- Purchase
Common Stock
2022-11-04$5.83/sh+972,212$5,667,996→ 2,147,212 total(indirect: See footnote) - Purchase
Non-Voting Common Stock
2022-11-04$5.83/sh+400,000$2,332,000→ 3,422,489 total(indirect: See footnote)→ Common Stock (400,000 underlying)
Holdings
- 79,726(indirect: See footnote)
Non-Voting Common Stock
→ Common Stock (79,726 underlying)
Footnotes (3)
- [F1]These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). The reporting person may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, (iv) MVA Investors, LLC and (v) Joe Lewis (collectively, the "Boxer Group"). The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein.
- [F2]Each share of Non-Voting Common Stock is convertible into one share of Common Stock at any time at the option of the holder without payment or additional consideration, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer.
- [F3]These securities are owned directly by MVA Investors, LLC, which may be deemed to be a member of the Boxer Group. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein.